Skip to main content

Risiken und Heilungschancen bei der Tumortherapie

  • Chapter
Strahlentherapie

Zusammenfassung

Bei der Tumortherapie sind die beiden folgenden Therapieziele optimal zu vereinen:

  1. 1.

    die Vernichtung des Tumors (Tumorheilung)

  2. 2.

    die Vermeidung von Nebenwirkungen (Komplikationen) der Therapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. New Eng J Med 294: 405–410

    Article  PubMed  CAS  Google Scholar 

  • Busch M (1978) Ãœberlegungen zur Verbesserung der standardisierten Tumortherapie. In: Messserschmidt O (Hrsg) Risiken und Nutzen der Strahlentherapie bösartiger Tumoren. Strahlenschutz in Forschung und Praxis, Bd 19. Thieme, Stuttgart, S 10–17

    Google Scholar 

  • Busch M (1980) Principles of an oncologic computer dialogue. In: Umegaki Y (Ed) Computers in radiation therapy. Proceedings. Japan Radiological Society, Tokyo, pp 403–407

    Google Scholar 

  • Busch M, Popp FA (1975) Der Volumenfaktor in der Strahlentherapie. Strahlentherapie 149: 75–92

    PubMed  CAS  Google Scholar 

  • Busch M, Wendhausen H (1978) General stochastical outline of tumor therapy. In: Rosenow U (ed) Computers in radiation therapy. Proceedings of an International Conference. Universitätsklinik Göttingen, pp 189–198

    Google Scholar 

  • Cohen L (1968) Theoretical iso-survival formulae for fractionated radiation therapy. Brit J Radiol 41: 522–528

    Article  PubMed  CAS  Google Scholar 

  • Cohen L (1977) Diskussionsbeitrag. 6th International Conference on the Use of Computers in Radiation Therapy. Göttingen

    Google Scholar 

  • Ellis F (1968) Relationship of biological effects to dose-time-fractionation factors in radiotherapy. In: Ebert M, Howard H (eds) Current topics in radiation research, vol 4. North-Holland, Amsterdam, p 357

    Google Scholar 

  • Ellis F (1969) Dose, time and fractionation: a clinical hypothesis. Clin Radiol 20: 1–7

    Article  PubMed  CAS  Google Scholar 

  • Goodman R, Mauch P, Piro A, Rosenthal D, Goldstein M, Tullis J, Hellman S (1977) Stages IIB and IIIB Hodgkin’s disease. Results of combined modality treatment. Cancer 40: 84–89

    Google Scholar 

  • Gremmel H, Wendhausen H (1977) Berücksichtigung der Volumenabhängigkeit von Toleranzdosen. Strahlentherapie 153: 462–466

    PubMed  CAS  Google Scholar 

  • Gremmel H, Hebbinghaus D, Wendhausen H (1978) An optimization criterion for dose distributions minimizing the radiation effect on healthy tissue. In: Rosenow U (ed) Computers in radiation therapie. Proceedings of an International Conference. Universitätsklinik Göttingen, pp 199–209

    Google Scholar 

  • Herring DF, Compton DMJ (1971) The degree of precision required in the radiation dose delivered in cancer radiotherapy. In: Glicksman A, et al. (eds) Computers in radiotherapy. British Institute of Radiology. London, pp 51–58

    Google Scholar 

  • Holthusen H (1936) Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen und deren Nutzanwendung zur Verhütung von Schäden. Strahlentherapie 57: 254–269

    Google Scholar 

  • Kaplan HS (1972) Hodgkin’s disease. Harvard Univ. Press, Cambridge, MA, p 284 Kellerer AM (1977) Grundlagen der Ellis-Formel. Strahlentherapie 153: 384–392

    Google Scholar 

  • Kirk J, Gray WM, Watson ER (1971) Cumulative radiation effect; part I: fractionated treatment regimes. Clin Radiol 22: 145–155

    Article  PubMed  CAS  Google Scholar 

  • Kirk J, Gray WM, Watson ER (1972) Cumulative radiation effect; part II: continuous radiation therapy–long-lived sources. Clin Radiol 23: 93–105

    Article  PubMed  CAS  Google Scholar 

  • Kirk J, Gray WM, Watson ER (1973) Cumulative radiation effect; part III: continuous radiation therapy–short-lived-sources. Clin Radiol 24: 1–11

    Article  PubMed  CAS  Google Scholar 

  • Kirk J, Gray WM, Watson ER (1975a) Cumulative radiation effect; part IV: normalisation of fractionated and continuous therapy–area and volume correction factors. Clin Radiol 26: 77–88

    Article  PubMed  CAS  Google Scholar 

  • Kirk J, Gray WM, Watson ER (1975b) Cumulative radiation effect; part V: time gaps in treatment regimes. Clin Radiol 26: 159–176

    Article  Google Scholar 

  • Kirk J, Wingate GWH, Watson ER (1976) High dose effects in the treatment of carcinoma of the bladder under air and hyperbaric oxygen conditions. Clin Radiol 27: 137–144

    Article  PubMed  CAS  Google Scholar 

  • Kirk J, Gray WM, Watson ER (1977a) Cumulative radiation effect; part VI: simple nomographie and tabular methods for the solution of practical problems. Clin Radiol 28: 29–74

    Article  PubMed  CAS  Google Scholar 

  • Kirk J, Cain O, Gray WM (1977b) Cumulative radiation effect; part VII: computer calculations and applications in clinical practice. Clin Radiol 28: 75–92

    Article  PubMed  CAS  Google Scholar 

  • Morrison R (1975) The results of the treatment of cancer of the bladder–a clinical contribution to radiobiology. Clin Radiol 26: 67–75

    Article  PubMed  CAS  Google Scholar 

  • Okumura Y, Norimura T, Okajima S (1983) Relationship between cure rate of human cancer and delivered dose in radiotherapy. Strahlentherapie 159: 109–114

    PubMed  CAS  Google Scholar 

  • Orton CG (1974) Time-dose factors (TDFs) in brachytherapy. Brit J Radiol 47: 603–607

    Article  PubMed  CAS  Google Scholar 

  • Phillips TL, Margolis L (1972) Radiation pathology and the clinical response of lung and esophagus. Front Radiat Ther Oncol 6: 254

    Google Scholar 

  • Scherer E (1978) Klinische Ãœbersicht zu Fragen der Heilungschancen und Schädigungsmöglichkeiten bei der radiologischen Tumortherapie. In: Messerschmidt O (Hrsg) Risiken und Nutzen der Strahlentherapie bösartiger Tumoren. Strahlenschutz in Forschung und Praxis, Bd 19. Thieme, Stuttgart, S 1–10

    Google Scholar 

  • Schmidt CG, Seeber S (1979) Chemotherapie testikulärer Tumoren. Dtsch med Wschr 104: 1488–1493

    Article  PubMed  CAS  Google Scholar 

  • Seeber S, Schilcher RB, Swosdyk P, Scheulen ME, Schmidt CG (in print) Combined modality treatment of small cell bronchiogenic carcinoma - A follow-up study of fifty cases. Proceedings of the E.O.R.T.C. Symposium on Progress and Perspectives in Lung Cancer Treatment, Brussels, 1979

    Google Scholar 

  • Shukowsky LJ (1970) Dose, time, volume relationships in squamous cell carcinoma of the supraglottic larynx. Amer J Roentgenol 108: 27–29

    Google Scholar 

  • Stewart JG, Jackson AW, Easson EC (1968) A clinical approach to neutron therapy. In: Ebert M, Howard A (eds) Current topics in radiation research, vol III. North Holland, Amsterdam, pp 175–206

    Google Scholar 

  • Swan GW (1981) Lecture notes in biomathematics. Springer, Berlin Heidelberg New York, pp 173–174

    Google Scholar 

  • Trott K.R (1979) Diskussionsbemerkung und Vortrag, Essen

    Google Scholar 

  • Wolbarst AB, Chin LM, Svensson GK (1982) Optimization of radiation therapy: integral response of a model biological system. Int J Radiat Oncol Biol Phys 8: 1761–1769

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Busch, M. (1987). Risiken und Heilungschancen bei der Tumortherapie. In: Scherer, E. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96891-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96891-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-96892-1

  • Online ISBN: 978-3-642-96891-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics